Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gutwein

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Neoplasia (New York, N.Y.)|February 27, 2013
MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patientsKai Doberstein, Nico Steinmeyer, Ann-Kathrin Hartmetz, et al.
Carcinogenesis|November 25, 2010
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cellsKai Doberstein, Anja Wieland, Sophia B Boyoung Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cellsPaul Gutwein, Alexander Stoeck, Svenja Riedle, et al.
Biochemical and Biophysical Research Communications|March 3, 2009
Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinomaPaul Gutwein, Anja Schramme, Beren Voss, et al.
Plos One|August 31, 2011
PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cellsSophia Boyoung Lee, Kai Doberstein, Peter Baumgarten, et al.
International Journal of Cancer|February 11, 2005
L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomasDaniela Gast, Svenja Riedle, Svenja Riedle, et al.
Journal of Biomedical Science|January 15, 2010
ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseasesPaul Gutwein, Anja Schramme, Mohamed Sadek Abdel-Bakky, et al.
The Journal of Investigative Dermatology|October 30, 2009
ADAM10 is upregulated in melanoma metastasis compared with primary melanomaSophia B Lee, Anja Schramme, Kai Doberstein, et al.
Journal of Cellular and Molecular Medicine|May 12, 2009
CXCL16 and oxLDL are induced in the onset of diabetic nephropathyPaul Gutwein, Mohamed Sadek Abdel-Bakky, Kai Doberstein, et al.
The American Journal of Pathology|May 14, 2009
CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoproteinPaul Gutwein, Mohamed Sadek Abdel-Bakky, Anja Schramme, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Neoplasia (New York, N.Y.)|February 27, 2013
MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patientsKai Doberstein, Nico Steinmeyer, Ann-Kathrin Hartmetz, et al.
Carcinogenesis|November 25, 2010
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cellsKai Doberstein, Anja Wieland, Sophia B Boyoung Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cellsPaul Gutwein, Alexander Stoeck, Svenja Riedle, et al.
Biochemical and Biophysical Research Communications|March 3, 2009
Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinomaPaul Gutwein, Anja Schramme, Beren Voss, et al.
Plos One|August 31, 2011
PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cellsSophia Boyoung Lee, Kai Doberstein, Peter Baumgarten, et al.
International Journal of Cancer|February 11, 2005
L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomasDaniela Gast, Svenja Riedle, Svenja Riedle, et al.
Journal of Biomedical Science|January 15, 2010
ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseasesPaul Gutwein, Anja Schramme, Mohamed Sadek Abdel-Bakky, et al.
The Journal of Investigative Dermatology|October 30, 2009
ADAM10 is upregulated in melanoma metastasis compared with primary melanomaSophia B Lee, Anja Schramme, Kai Doberstein, et al.
Journal of Cellular and Molecular Medicine|May 12, 2009
CXCL16 and oxLDL are induced in the onset of diabetic nephropathyPaul Gutwein, Mohamed Sadek Abdel-Bakky, Kai Doberstein, et al.
The American Journal of Pathology|May 14, 2009
CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoproteinPaul Gutwein, Mohamed Sadek Abdel-Bakky, Anja Schramme, et al.
Pageof 4